Related Experiment Video

Updated: Jun 19, 2026

Investigation of the Transcriptional Role of a RUNX1 Intronic Silencer by CRISPR/Cas9 Ribonucleoprotein in Acute Myeloid Leukemia Cells
09:16

Investigation of the Transcriptional Role of a RUNX1 Intronic Silencer by CRISPR/Cas9 Ribonucleoprotein in Acute Myeloid Leukemia Cells

Published on: September 1, 2019

Altered Runx1 subnuclear targeting enhances myeloid cell proliferation and blocks differentiation by activating a

Sayyed K Zaidi1, Christopher R Dowdy, Andre J van Wijnen

  • 1Department of Cell Biology, University of Massachusetts Medical School and Cancer Center, Worcester, Massachusetts 01655, USA.

Cancer Research
|October 15, 2009
PubMed

Insights

Disrupted Runx1/AML1 function in acute myeloid leukemia (AML) triggers specific micro-RNAs (miRs). These miRs, particularly miR-24, promote myeloid cell growth and block differentiation via MAPK signaling, contributing to leukemia development.

Area of Science:

  • Molecular Biology
  • Cancer Research
  • Hematology

Background:

  • Runx1/AML1 is crucial for hematopoiesis.
  • Disrupted Runx1/AML1 localization, via mutation or translocation t(8;21), is implicated in acute myeloid leukemia (AML) pathogenesis.
  • The role of micro-RNAs (miRs) in AML driven by Runx1/AML1 dysfunction is not fully understood.

Purpose of the Study:

  • To investigate the role of micro-RNAs (miRs) in AML caused by Runx1/AML1 disruption.
  • To elucidate the mechanism by which miR-24 affects myeloid cell proliferation and differentiation in the context of AML.
  • To determine the relationship between Runx1, AML1-ETO, and miR-24 in t(8;21) AML.

Main Methods:

  • Analysis of micro-RNA expression in myeloid progenitor cells and AML patient samples.
  • Chromatin immunoprecipitation to assess Runx1 and AML1-ETO binding to the miR-24-23-27 locus.
  • Quantitative real-time PCR to measure miR-24 and target gene expression.
  • Western blotting to evaluate MAPK pathway activation.
  • Cell proliferation and differentiation assays.

Main Results:

  • Runx1 disruption and the t(8;21) translocation induce specific miRs, including miR-24.
  • Runx1 and AML1-ETO directly regulate miR-24 transcription at the miR-24-23-27 locus.
  • miR-24 downregulates MAPK phosphatase-7, leading to increased c-jun-NH(2)-kinase and p38 phosphorylation.
  • Overexpression of miR-24 enhances myeloid cell proliferation, promotes interleukin-3 independence, and inhibits granulocytic differentiation.

Conclusions:

  • Compromised Runx1 function initiates a miR-dependent pathway in AML.
  • This pathway, involving miR-24 and MAPK signaling, promotes myeloid proliferation while blocking differentiation, contributing to leukemogenesis.
  • Targeting miR-24 or its downstream effectors may offer therapeutic strategies for AML.

More Related Videos

Proliferation and Differentiation of Murine Myeloid Precursor 32D/G-CSF-R Cells10:21

Proliferation and Differentiation of Murine Myeloid Precursor 32D/G-CSF-R Cells

Published on: February 21, 2018

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants07:38

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants

Published on: June 6, 2025

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA ends...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...